Effect of phenobarbitone and pre-eclamptic toxaemia on neonatal jaundice.
D001463:Barbiturates / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D007567:Jaundice, Neonatal / Q000517:prevention & control*; D008431:Maternal-Fetal Exchange; D010634:Phenobarbital / Q000627:therapeutic use*; D011225:Pre-Eclampsia / Q000188:drug therapy*; D011247:Pregnancy
D001463:Barbiturates; D010634:Phenobarbital